Atlas Trials

A Study to Evaluate the Efficacy and Safety of SYHX1901 Tablet in Non-segmental Vitiligo Patients

Clinical trial NCT06511739 · UNKNOWN

Trial details

NCT number
NCT06511739
Sponsor
CSPC Ouyi Pharmaceutical Co., Ltd.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Non-segmental Vitiligo
Start date
2024-05-27
Primary completion
2025-08-01
Enrollment
144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.